FDA Inspection
The Procter & Gamble Manufacturing CompanyThe Procter & Gamble Manufacturing Company – FDA Inspection, Nov 17, 2017
Record Details
This FDA Inspection record concerns The Procter & Gamble Manufacturing Company, with an inspection on November 17, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 89ff499d-7d3a-4e4e-9172-7274687dd04b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1031577
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.198(a)Complaint Handling Procedure
- 21 CFR 211.165(a)Testing and release for distribution
Full citation text and observation details available on the Dashboard.
Other FDA inspections of The Procter & Gamble Manufacturing Company
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 9, 2026 | Not classified | Atlanta District Office | Drug Quality Assurance |
| March 10, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 6, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 18, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 5, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for The Procter & Gamble Manufacturing Company
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.